Skip links

Main navigation

Bert Vogelstein, MD

Department Affiliations Oncology, Pathology,Molecular Biology & Genetics Member of the National Academy of Sciences, Investigator of the Howard Hughes Medical Institute
Rank Clayton Professor
Office Phone 410-955-8878
Lab Phone
Fax 410-955-0548
Email vogelbe@jhmi.edu
SOM Address Room 589 Cancer Research Building I
Website

Students

Steven Laken 1994 – 1999

Chetan Bettegowda 2000 – 2005

Harith Rajagoalan 2000 – 2004

Saurabh Saha 2000 – 2003

Ian Cheong 2001 – 2006

Jordan Cummins 2001 – 2005

Carlo Rago 2001 – 2009

Jihye Yun 2003 – 2009

Laura DeLong Wood 2004 – 2007

Kibem Antonio Kim 2005 2015

Jimmy Lin 2005 – 2011
Isaac Kinde 2007- 2015
Yuxuan Wang 2011
Jackie Douglass 2013
Michael Hwang 2013
Steve Lu 2014
Austin Mattox 2014

Research Interests

Our group has studied the genetics of human cancer for 30 years and has played a major role in elucidating the following principles governing the pathogenesis of human neoplasia. (i) Human tumors represent the expansion of a single transformed cell. (ii) The initiation of this process and the expansion of the transformed cell are due to mutations in specific oncogenes and tumor suppressor genes. (iii) These mutations occur in a preferred order as the tumor progresses from benign to malignant stages. (iv) Mutations in the same genes can occur either through inherited or somatic pathways. (v) Naturally occurring mutations in these genes can provide critical clues to their biochemical and physiologic functions. (vi) Heritable alterations affecting genetic stability can lead to an accelerated accumulation of somatic mutations and an associated predisposition to cancer. (vii) Knowledge of the genetic alterations responsible for cancer can be used to develop innovative approaches to improve the management of patients with neoplastic disease. Our current research is focused on point (vii): the development of novel therapeutic and diagnostic approaches for cancer patients and the development of methods to detect cancers before they have metastasized.

Publications

  • Diaz, L.A. Jr., Williams, R.T., Wu., J., Kinde, I., Hecht, J.R., Berlin, J., Allen, B., Bozic, I., Reiter, J.G., Nowak, M.A., Kinzler, K.W., Oliner, K.S. and Vogelstein, B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486: 537-540, 2012. PMCID: PMC3436069.
  • Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr. and Kinzler, K.W. Cancer genome landscapes. Science 339:1546-1558, 2013 PMID: 23539594 Journal – in Process.
  • Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, IeM., Kurman, R., Dao, F., Levine, D.A., Giuntoli, R., Roden, R., Eshleman, J.R., Carvalho, J.P., Marie, S.K., Papadopoulos, N., Kinzler, K.W., Vogelstein, B. and Diaz, L.A. Jr. Evaluation of DNA from the papanicolaou test detect ovarian and endometrial cancers. Sci. Transl. Med. 5: 167ra4, 2013. PMID: 23303603 Journal – in Process.